10-K Filing

TEVA PHARMACEUTICAL INDUSTRIES LTD CIK: 818686 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001193125-21-036239`
Period End Date	20201231
Filing Date	20210210
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	d102112d10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 128 Cash Flow Statement 118 Stockholders Equity 33 Comprehensive Income 35

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$135.00M	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$126.00M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.10	CHF	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	0.10	CHF	Point-in-time
Ordinary shares, authorized	`CommonStockSharesAuthorized`	2.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.98B	USD	Point-in-time
Ordinary shares, authorized	`CommonStockSharesAuthorized`	2.50B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.18B	USD	Point-in-time
Ordinary shares, issued	`CommonStockSharesIssued`	1.20B	shares	Point-in-time
Ordinary shares, issued	`CommonStockSharesIssued`	1.20B	shares	Point-in-time
Accounts receivables, net of allowance for credit losses of $126 million and $135 million as of December 31, 2020 and December 31, 2019	`AccountsReceivableNetCurrent`	$4.58B	USD	Point-in-time
Accounts receivables, net of allowance for credit losses of $126 million and $135 million as of December 31, 2020 and December 31, 2019	`AccountsReceivableNetCurrent`	$5.68B	USD	Point-in-time
Inventories	`InventoryNet`	$4.42B	USD	Point-in-time
Treasury shares	`TreasuryStockShares`	106.00M	shares	Point-in-time
Treasury shares	`TreasuryStockShares`	106.00M	shares	Point-in-time
Inventories	`InventoryNet`	$4.40B	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$945.00M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$870.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$434.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$710.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$189.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$87.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.46B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.01B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$695.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$386.00M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$538.00M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$591.00M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$6.44B	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$6.30B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$514.00M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$559.00M	USD	Point-in-time
Identifiable intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$8.92B	USD	Point-in-time
Identifiable intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$11.23B	USD	Point-in-time
Goodwill	`Goodwill`	$20.62B	USD	Point-in-time
Goodwill	`Goodwill`	$24.85B	USD	Point-in-time
Goodwill	`Goodwill`	$24.92B	USD	Point-in-time
Total assets	`Assets`	$57.47B	USD	Point-in-time
Total assets	`Assets`	$50.64B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$3.19B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$2.35B	USD	Point-in-time
Sales reserves and allowances	`SalesReservesAndAllowances`	$4.82B	USD	Point-in-time
Sales reserves and allowances	`SalesReservesAndAllowances`	$6.16B	USD	Point-in-time
Accounts payables	`AccountsPayableTradeCurrent`	$1.76B	USD	Point-in-time
Accounts payables	`AccountsPayableTradeCurrent`	$1.72B	USD	Point-in-time
Employee-related obligations	`EmployeeRelatedLiabilitiesCurrent`	$693.00M	USD	Point-in-time
Employee-related obligations	`EmployeeRelatedLiabilitiesCurrent`	$685.00M	USD	Point-in-time
Accrued expenses	`AccruedExpenses`	$1.87B	USD	Point-in-time
Accrued expenses	`AccruedExpenses`	$1.78B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$933.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$889.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.67B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.16B	USD	Point-in-time
Deferred income taxes	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$964.00M	USD	Point-in-time
Deferred income taxes	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$1.10B	USD	Point-in-time
Other taxes and long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.64B	USD	Point-in-time
Other taxes and long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.24B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$24.56B	USD	Point-in-time
Senior notes and loans	`LongTermNotesAndLoans`	$22.73B	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$479.00M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$435.00M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$28.73B	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$26.41B	USD	Point-in-time
Commitments and contingencies, see note 12	`CommitmentsAndContingencies`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$39.58B	USD	Point-in-time
Total liabilities	`Liabilities`	$42.41B	USD	Point-in-time
Ordinary shares of NIS 0.10 par value per share; December 31, 2020 and December 31, 2019: authorized 2,495 million shares; issued 1,202 million shares and 1,198 million shares, respectively	`CommonStockValue`	$56.00M	USD	Point-in-time
Ordinary shares of NIS 0.10 par value per share; December 31, 2020 and December 31, 2019: authorized 2,495 million shares; issued 1,202 million shares and 1,198 million shares, respectively	`CommonStockValue`	$57.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$27.31B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$27.44B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.95B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.96B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.31B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.40B	USD	Point-in-time
Treasury shares as of December 31, 2020 and December 31, 2019: 106 million ordinary shares	`TreasuryStockValue`	$4.13B	USD	Point-in-time
Treasury shares as of December 31, 2020 and December 31, 2019: 106 million ordinary shares	`TreasuryStockValue`	$4.13B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$13.97B	USD	Point-in-time
Stockholders' equity attributable to Teva shareholders	`StockholdersEquity`	$10.03B	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$1.09B	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$1.03B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.79B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.75B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.06B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.06B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$57.47B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$50.64B	USD	Point-in-time

Income Statement 128 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.18B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.36B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.87B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.45B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.09B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.15B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$18.27B	USD	Annual
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.47B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$16.89B	USD	Annual
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$3.98B	USD	1 Quarter
Net revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$16.66B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$8.93B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$9.97B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$9.35B	USD	Annual
Gross profit	`GrossProfit`	$1.89B	USD	1 Quarter
Gross profit	`GrossProfit`	$2.05B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.76B	USD	1 Quarter
Gross profit	`GrossProfit`	$2.06B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.83B	USD	1 Quarter
Gross profit	`GrossProfit`	$8.30B	USD	Annual
Gross profit	`GrossProfit`	$1.96B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.86B	USD	1 Quarter
Gross profit	`GrossProfit`	$7.54B	USD	Annual
Gross profit	`GrossProfit`	$7.73B	USD	Annual
Gross profit	`GrossProfit`	$1.85B	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.01B	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$997.00M	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$1.21B	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$2.61B	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$2.50B	USD	Annual
Selling and marketing expenses	`SellingAndMarketingExpense`	$2.92B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.19B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.17B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.30B	USD	Annual
Intangible assets impairments	`IntangibleAssetsImpairments`	$1.99B	USD	Annual
Intangible assets impairments	`IntangibleAssetsImpairments`	$1.64B	USD	Annual
Intangible assets impairments	`IntangibleAssetsImpairments`	$1.50B	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$3.03B	USD	Annual
Goodwill impairment	`GoodwillImpairmentLoss`	$4.63B	USD	Annual
Other asset impairments, restructuring and other items	`ImpairmentsRestructuringAndOthers`	$423.00M	USD	Annual
Other asset impairments, restructuring and other items	`ImpairmentsRestructuringAndOthers`	$987.00M	USD	Annual
Other asset impairments, restructuring and other items	`ImpairmentsRestructuringAndOthers`	$479.00M	USD	Annual
Legal settlements and loss contingencies	`LegalSettlementsAndLossContingencies`	$-1.21B	USD	Annual
Legal settlements and loss contingencies	`LegalSettlementsAndLossContingencies`	$1.18B	USD	Annual
Legal settlements and loss contingencies	`LegalSettlementsAndLossContingencies`	$60.00M	USD	Annual
Other income	`OtherOperatingIncomeExpenseNet`	$291.00M	USD	Annual
Other income	`OtherOperatingIncomeExpenseNet`	$76.00M	USD	Annual
Other income	`OtherOperatingIncomeExpenseNet`	$40.00M	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$-3.57B	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$-443.00M	USD	Annual
Operating (loss) income	`OperatingIncomeLoss`	$-1.64B	USD	Annual
Financial expenses, net	`NonoperatingIncomeExpense`	$-959.00M	USD	Annual
Financial expenses, net	`NonoperatingIncomeExpense`	$-834.00M	USD	Annual
Financial expenses, net	`NonoperatingIncomeExpense`	$-822.00M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.41B	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.60B	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.26B	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$-278.00M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$-195.00M	USD	Annual
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	$-168.00M	USD	Annual
Share in (profits) losses of associated companies, net	`IncomeLossFromEquityMethodInvestments`	$-13.00M	USD	Annual
Share in (profits) losses of associated companies, net	`IncomeLossFromEquityMethodInvestments`	$-71.00M	USD	Annual
Share in (profits) losses of associated companies, net	`IncomeLossFromEquityMethodInvestments`	$138.00M	USD	Annual
Net income (loss)	`ProfitLoss`	$-2.47B	USD	Annual
Net income (loss)	`ProfitLoss`	$-97.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-307.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$75.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.34B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$53.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$25.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.00B	USD	Annual
Net income (loss)	`ProfitLoss`	$162.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.10B	USD	Annual
Net income (loss)	`ProfitLoss`	$-671.00M	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.00M	USD	Annual
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-322.00M	USD	Annual
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-109.00M	USD	Annual
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-105.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-4.35B	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-2.15B	USD	Annual
Net income (loss) attributable to Teva	`NetIncomeLoss`	$140.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-314.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-3.99B	USD	Annual
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-999.00M	USD	Annual
Net income (loss) attributable to Teva	`NetIncomeLoss`	$110.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$150.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$-689.00M	USD	1 Quarter
Net income (loss) attributable to Teva	`NetIncomeLoss`	$69.00M	USD	1 Quarter
Accrued dividends on preferred shares	`PreferredStockDividendsIncomeStatementImpact`	$249.00M	USD	Annual
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$150.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.99B	USD	Annual
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-314.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$110.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-105.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$69.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.35B	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$140.00M	USD	1 Quarter
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-999.00M	USD	Annual
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.40B	USD	Annual
Net income (loss) attributable to ordinary shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-689.00M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.10	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.06	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.91	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.29	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.14	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-3.97	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-2.35	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.10	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-3.64	USD	Annual
Basic	`EarningsPerShareBasic`	$-0.63	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.13	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.10	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.14	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.63	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.13	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.10	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-3.64	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-2.35	USD	Annual
Diluted	`EarningsPerShareDiluted`	$-0.29	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-3.97	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.91	USD	Annual
Diluted	`EarningsPerShareDiluted`	$0.06	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.09B	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.09B	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.09B	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.09B	shares	Annual

Cash Flow Statement 118 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-2.47B	USD	Annual
Net income (loss)	`ProfitLoss`	$-97.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-307.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$75.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.34B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$53.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$25.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.00B	USD	Annual
Net income (loss)	`ProfitLoss`	$162.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.10B	USD	Annual
Net income (loss)	`ProfitLoss`	$-671.00M	USD	1 Quarter
Impairment of goodwill, long-lived assets and assets held for sale	`AssetImpairmentCharges`	$5.62B	USD	Annual
Impairment of goodwill, long-lived assets and assets held for sale	`AssetImpairmentCharges`	$1.78B	USD	Annual
Impairment of goodwill, long-lived assets and assets held for sale	`AssetImpairmentCharges`	$6.55B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.72B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.56B	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.84B	USD	Annual
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$1.82B	USD	Annual
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$896.00M	USD	Annual
Net change in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$2.19B	USD	Annual
Deferred income taxes, net and uncertain tax positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-696.00M	USD	Annual
Deferred income taxes, net and uncertain tax positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-837.00M	USD	Annual
Deferred income taxes, net and uncertain tax positions	`DeferredIncomeTaxesNetAndUncertainTaxPositions`	$-985.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$119.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$129.00M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$155.00M	USD	Annual
Other items	`OtherOperatingActivitiesCashFlowStatement`	$-135.00M	USD	Annual
Other items	`OtherOperatingActivitiesCashFlowStatement`	$100.00M	USD	Annual
Other items	`OtherOperatingActivitiesCashFlowStatement`	$28.00M	USD	Annual
Research and development in process	`ResearchAndDevelopmentInProcess`	-	USD	Annual
Research and development in process	`ResearchAndDevelopmentInProcess`	$80.00M	USD	Annual
Research and development in process	`ResearchAndDevelopmentInProcess`	$114.00M	USD	Annual
Net loss (gain) from investments and from sale of long lived assets	`ProfitFromSaleOfLongLivedAssetsAndInvestment`	$213.00M	USD	Annual
Net loss (gain) from investments and from sale of long lived assets	`ProfitFromSaleOfLongLivedAssetsAndInvestment`	$19.00M	USD	Annual
Net loss (gain) from investments and from sale of long lived assets	`ProfitFromSaleOfLongLivedAssetsAndInvestment`	$18.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.45B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$748.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.22B	USD	Annual
Beneficial interest collected in exchange for securitized trade receivables	`ProceedsFromBeneficialInterestInExchangeForSecuritizedTradeReceivables`	$1.41B	USD	Annual
Beneficial interest collected in exchange for securitized trade receivables	`ProceedsFromBeneficialInterestInExchangeForSecuritizedTradeReceivables`	$1.74B	USD	Annual
Beneficial interest collected in exchange for securitized trade receivables	`ProceedsFromBeneficialInterestInExchangeForSecuritizedTradeReceivables`	$1.49B	USD	Annual
Proceeds from sales of long-lived assets and investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$67.00M	USD	Annual
Proceeds from sales of long-lived assets and investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$890.00M	USD	Annual
Proceeds from sales of long-lived assets and investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$343.00M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$525.00M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$578.00M	USD	Annual
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$651.00M	USD	Annual
Purchases of investments and other assets	`PaymentToAcquireMarketableSecuritiesAndOtherAssets`	$119.00M	USD	Annual
Purchases of investments and other assets	`PaymentToAcquireMarketableSecuritiesAndOtherAssets`	$55.00M	USD	Annual
Purchases of investments and other assets	`PaymentToAcquireMarketableSecuritiesAndOtherAssets`	$8.00M	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-24.00M	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-58.00M	USD	Annual
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$-11.00M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.35B	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.87B	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$863.00M	USD	Annual
Repayment of senior notes and loans and other long-term liabilities	`RepaymentsOfLongTermDebt`	$1.87B	USD	Annual
Repayment of senior notes and loans and other long-term liabilities	`RepaymentsOfLongTermDebt`	$7.45B	USD	Annual
Repayment of senior notes and loans and other long-term liabilities	`RepaymentsOfLongTermDebt`	$3.94B	USD	Annual
Proceeds from senior notes and loans, net of issuance costs	`ProceedsFromDebtNetOfIssuanceCosts`	$4.43B	USD	Annual
Proceeds from senior notes and loans, net of issuance costs	`ProceedsFromDebtNetOfIssuanceCosts`	$2.08B	USD	Annual
Proceeds from senior notes and loans, net of issuance costs	`ProceedsFromDebtNetOfIssuanceCosts`	-	USD	Annual
Proceeds from short term debt	`ProceedsFromShortTermDebt`	$500.00M	USD	Annual
Proceeds from short term debt	`ProceedsFromShortTermDebt`	-	USD	Annual
Proceeds from short term debt	`ProceedsFromShortTermDebt`	$550.00M	USD	Annual
Repayment of short term debt	`RepaymentsOfShortTermDebt`	$502.00M	USD	Annual
Repayment of short term debt	`RepaymentsOfShortTermDebt`	$260.00M	USD	Annual
Repayment of short term debt	`RepaymentsOfShortTermDebt`	$559.00M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-57.00M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-5.00M	USD	Annual
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-11.00M	USD	Annual
Tax withholding payments made on shares and dividends	`PaymentsRelatedToTaxWithholdingForSharesAndDividend`	$22.00M	USD	Annual
Tax withholding payments made on shares and dividends	`PaymentsRelatedToTaxWithholdingForSharesAndDividend`	-	USD	Annual
Tax withholding payments made on shares and dividends	`PaymentsRelatedToTaxWithholdingForSharesAndDividend`	$52.00M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.93B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.35B	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.89B	USD	Annual
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.00M	USD	Annual
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.00M	USD	Annual
Translation adjustment on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-142.00M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$193.00M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$202.00M	USD	Annual
Net change in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$819.00M	USD	Annual
Balance of cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Balance of cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$963.00M	USD	Point-in-time
Balance of cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.18B	USD	Point-in-time
Balance of cash and cash equivalents at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.78B	USD	Point-in-time
Balance of cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.98B	USD	Point-in-time
Balance of cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$963.00M	USD	Point-in-time
Balance of cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.18B	USD	Point-in-time
Balance of cash and cash equivalents at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.78B	USD	Point-in-time
Beneficial interest obtained in exchange for securitized trade receivables	`BeneficialInterestObtainedInExchangeForSecuritizedTradeReceivables`	$1.72B	USD	Point-in-time
Beneficial interest obtained in exchange for securitized trade receivables	`BeneficialInterestObtainedInExchangeForSecuritizedTradeReceivables`	$1.40B	USD	Point-in-time
Beneficial interest obtained in exchange for securitized trade receivables	`BeneficialInterestObtainedInExchangeForSecuritizedTradeReceivables`	$1.51B	USD	Point-in-time
Conversion of mandatory convertible preferred shares into ordinary shares	`ConversionOfStockAmountConverted1`	$3.88B	USD	Annual
Conversion of mandatory convertible preferred shares into ordinary shares	`ConversionOfStockAmountConverted1`	-	USD	Annual
Conversion of mandatory convertible preferred shares into ordinary shares	`ConversionOfStockAmountConverted1`	-	USD	Annual
Interest	`InterestPaidNet`	$815.00M	USD	Annual
Interest	`InterestPaidNet`	$840.00M	USD	Annual
Interest	`InterestPaidNet`	$846.00M	USD	Annual
Income taxes, net of refunds	`IncomeTaxesPaidNet`	$420.00M	USD	Annual
Income taxes, net of refunds	`IncomeTaxesPaidNet`	$552.00M	USD	Annual
Income taxes, net of refunds	`IncomeTaxesPaidNet`	$709.00M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.42B	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.44B	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.47B	USD	Annual
Trade payables, accrued expenses, employee-related obligations and other liabilities	`IncreaseDecreaseInCertainCurrentLiabilitiesExcludingDebt`	$-463.00M	USD	Annual
Trade payables, accrued expenses, employee-related obligations and other liabilities	`IncreaseDecreaseInCertainCurrentLiabilitiesExcludingDebt`	$-500.00M	USD	Annual
Trade payables, accrued expenses, employee-related obligations and other liabilities	`IncreaseDecreaseInCertainCurrentLiabilitiesExcludingDebt`	$643.00M	USD	Annual
Trade receivables net of sales reserves and allowances	`IncreaseDecreaseInCertainCurrentAssetsExcludingInventories`	$-293.00M	USD	Annual
Trade receivables net of sales reserves and allowances	`IncreaseDecreaseInCertainCurrentAssetsExcludingInventories`	$88.00M	USD	Annual
Trade receivables net of sales reserves and allowances	`IncreaseDecreaseInCertainCurrentAssetsExcludingInventories`	$-394.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$41.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$26.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$271.00M	USD	Annual
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information	`NetChangeInItemsComprisingSupplementalDisclosureOfCashFlowInformation`	$-2.19B	USD	Annual
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information	`NetChangeInItemsComprisingSupplementalDisclosureOfCashFlowInformation`	$-1.82B	USD	Annual
Net Change In Items Comprising Supplemental Disclosure Of Cash Flow Information	`NetChangeInItemsComprisingSupplementalDisclosureOfCashFlowInformation`	$-896.00M	USD	Annual

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.79B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.75B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.06B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.06B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-2.47B	USD	Annual
Net income (loss)	`ProfitLoss`	$-97.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-307.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$75.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.34B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$53.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$25.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.00B	USD	Annual
Net income (loss)	`ProfitLoss`	$162.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.10B	USD	Annual
Net income (loss)	`ProfitLoss`	$-671.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-30.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-585.00M	USD	Annual
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$160.00M	USD	Annual
Issuance of Shares, value	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	Annual
Issuance of Shares, value	`StockIssuedDuringPeriodValueNewIssues`	$-52.00M	USD	Annual
Issuance of Treasury Shares	`TreasuryStockValueAcquiredCostMethod`	$4.00M	USD	Annual
Issuance of Treasury Shares	`TreasuryStockValueAcquiredCostMethod`	$6.00M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$129.00M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$155.00M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$119.00M	USD	Annual
Transactions with non-controlling interests	`TransactionsWithNonControllingInterests`	$-8.00M	USD	Annual
Transactions with non-controlling interests	`TransactionsWithNonControllingInterests`	$-1.00M	USD	Annual
Transactions with non-controlling interests	`TransactionsWithNonControllingInterests`	$-2.00M	USD	Annual
Other	`OtherEquity`	$-8.00M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.79B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$18.75B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.06B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.06B	USD	Point-in-time

Comprehensive Income 35 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-2.47B	USD	Annual
Net income (loss)	`ProfitLoss`	$-97.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-307.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$75.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.34B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$53.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$25.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.00B	USD	Annual
Net income (loss)	`ProfitLoss`	$162.00M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-4.10B	USD	Annual
Net income (loss)	`ProfitLoss`	$-671.00M	USD	1 Quarter
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-713.00M	USD	Annual
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$97.00M	USD	Annual
Currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-69.00M	USD	Annual
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-84.00M	USD	Annual
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-115.00M	USD	Annual
Unrealized gain (loss) on derivative financial instruments, net	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-57.00M	USD	Annual
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.00M	USD	Annual
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	Annual
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	-	USD	Annual
Unrealized gain (loss) on defined benefit plans, net	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$13.00M	USD	Annual
Unrealized gain (loss) on defined benefit plans, net	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-18.00M	USD	Annual
Unrealized gain (loss) on defined benefit plans, net	`OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax`	$-20.00M	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-30.00M	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-585.00M	USD	Annual
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$160.00M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.06B	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-840.00M	USD	Annual
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.13B	USD	Annual
Comprehensive income (loss) attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$12.00M	USD	Annual
Comprehensive income (loss) attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-296.00M	USD	Annual
Comprehensive income (loss) attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-53.00M	USD	Annual
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTax`	$-2.76B	USD	Annual
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTax`	$-852.00M	USD	Annual
Comprehensive income (loss) attributable to Teva	`ComprehensiveIncomeNetOfTax`	$-4.08B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.